In aged mice, repeated doses of the immune signal IL-4 shifted bone marrow progenitors back toward B and T lymphocytes and away from inflammatory myeloid cells. Treated mice did better on memory, motor and glucose tolerance tests, and transplanting IL-4-treated progenitors reproduced the benefits.
Chronic inflammation and aging skew hematopoiesis toward myelopoiesis. Starting with a screen to identify signals capable of restoring lymphoid lineage commitment in HSPCs, Yao et al.